Typhoid Vaccine
Vaccination against typhoid fever in travelers is not cost-effective
Published in TB and Outbreaks Week, November 30th, 2004
According to a study from Greece, "Analysis of data on the incidence of typhoid fever and the costs of vaccination of travelers to the developing world indicates that vaccination may not be cost-effective for travel to countries with a moderate-to-high endemicity. It may be reasonable to selectively vaccinate travelers to countries with a very high incidence of typhoid fever, and particularly those who are visiting relatives or who will be in close contact with the local population."
"Vaccination of travelers on standard tourist itineraries is probably not necessary," said V....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Bacterial Resistance
Indian Salmonella Typhi isolates have reduced ciprofloxacin susceptibility - HIV/AIDS & Tuberculosis
HIV has less effect on point prevalence of TB disease than on TB incidence - Meningococcal Epidemiology
New genetic lineages of Neisseria meningitides W135 continue to emerge - Tuberculosis
Genetic susceptibility to tuberculosis in Africans is polygenic - Tuberculosis
Serum IgE levels higher in tuberculosis patients coinfected with HIV/parasites - Anthrax
Company gets $877.5 million U.S. government contract to supply anthrax vaccine - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
